MedComm · Published 2026-07-22 · DOI 10.1002/mco2.70879
Yuke Ji, Sha Liu, Ying Zhang, Junya Zhu, Chang Huang, Ya Zhao, Jiao Xia, Wan Mu, Jin Yao, Biao Yan
ABSTRACT Retinal neurodegeneration leads to progressive and irreversible vision loss driven by retinal ganglion cell (RGC) death, yet effective neuroprotective therapies remain lacking. Recent studies suggest that small non‐coding RNAs play key roles in central nervous system injury, but their relevance to retinal neurodegeneration remains incompletely understood. Here, we identify a significant increase in 5ʹtiRNA‐His‐GTG, an ANG‐generated tRNA‐derived fragment, in mouse models of retinal neurodegeneration. Functionally, elevated 5ʹtiRNA‐His‐GTG promotes reactive gliosis and contributes to RGC degeneration through Müller cell‐RGC crosstalk. Conversely, inhibition of 5ʹtiRNA‐His‐GTG attenuates glial activation, preserves RGC survival, and improves visual function and vision‐dependent behaviors. Mechanistically, 5ʹtiRNA‐His‐GTG induces neurodegenerative changes by suppressing the LPCAT1‐mediated phosphatidylcholine (PC) biosynthetic pathway and perturbing glycerophospholipid metabolism. Notably, restoration of LPCAT1 expression or PC levels reverses 5ʹtiRNA‐His‐GTG‐induced neurodegeneration both in vitro and in vivo. These findings uncover a previously unrecognized 5ʹtiRNA‐His‐GTG‐LPCAT1‐PC regulatory pathway that contributes to retinal neurodegeneration. Collectively, our study identifies 5ʹtiRNA‐His‐GTG as a critical mediator of glial‐driven neuroinflammation and neuronal loss, and highlights this signaling axis as a potential therapeutic target for retinal neurodegeneration.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Ji, Y., Liu, S., Zhang, Y., et al. (2026). Reprogramming Glial Cell Metabolism via a tRNA Fragment Preserves Vision in Retinal Neurodegeneration. MedComm. https://doi.org/10.1002/mco2.70879